TARS
Tarsus Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$67.96
-0.21 ▼ -0.31%
🌙 3월 13일 4:57 PM ET (한국 3/14 05:57)
$67.96
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -1.61 | Insider Own | 6.19% | Shs Outstand | 0.04B | Perf Week | -7.23% |
| Market Cap | 2.89B | Forward P/E | 22.26 | EPS next Y | 586.8% | Insider Trans | -2.53% | Shs Float | 0.04B | Perf Month | 3.93% |
| Enterprise Value | 2.56B | PEG | - | EPS next Q | -0.35 | Inst Own | 102.99% | Short Float | 13.34% | Perf Quarter | -16.43% |
| Income | -0.07B | P/S | 6.41 | EPS this Y | 60.55% | Inst Trans | -1.81% | Short Ratio | 8.17 | Perf Half Y | 31.02% |
| Sales | 0.45B | P/B | 8.42 | EPS next 5Y | - | ROA | -14.07% | Short Interest | 5.33M | Perf YTD | -17% |
| Book/sh | 8.07 | P/C | 6.92 | EPS past 3/5Y | 14.26% -3.8% | ROE | -23.39% | 52W High | -20.28% ($85.25) | Perf Year | 46.24% |
| Cash/sh | 9.82 | P/FCF | - | Sales past 3/5Y | 159.54% - | ROIC | -15.57% | 52W Low | 76.47% ($38.51) | Perf 3Y | 378.93% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 48.11% | Gross Margin | 93.2% | Volatility(W/M) | 3.76% 5.17% | Perf 5Y | 102.87% |
| Dividend TTM | - | EV/Sales | 5.67 | Sales Y/Y TTM | 146.71% | Oper. Margin | -15.72% | ATR (14) | 3.39 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.82 | EPS Q/Q | 67.35% | Profit Margin | -14.72% | RSI (14) | 42.65 | Recom | 1.11 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.85 | Sales Q/Q | 128.39% | SMA20 | -4.25% ($70.98) | Beta | 0.63 | Target Price | $94.22 |
| Payout | - | Debt/Eq | 0.24 | Earnings | 2000000 | SMA50 | -4.04% ($70.82) | Rel Volume | 0.45 | Prev Close | $68.17 |
| Employees | 370 | LT Debt/Eq | 0.24 | EPS/Sales Surpr. | -115.05% 4.91% | SMA200 | 10.07% ($61.74) | Avg Volume(3M) | 0.65M | Price | $67.96 |
| IPO | 2020/10/16 | Option/Short | Yes/Yes | Trades | 4997 | Volume | 296,389 | Change | -0.31% |
뉴스 로딩 중...